LY2405319

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2405319, covering 2010-09-13 to 2017-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2405319 in Participants With Type 2 Diabetes [Phase 1]